• A 71-year-old Woman with CREST Syndrome and Multiple Waxy Facial Papules and Plaques: A Quiz
• A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery
• A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
• A Rare Case of Bullous Morphea Associated with Autoimmune Hepatitis
• Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
• Addressing LGBTQ+ health equity and disparities in multiple sclerosis: A call for research and action
• Anti-Th/To Antibodies in Scleroderma: Good Prognosis or Serious Concern?
• Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire
• Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies
• Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis
• Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis
• Autoimmunity in patients with inborn errors of immunity: A case series
• Bidirectional epigenetic editing reveals hierarchies in gene regulation
• Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study
• Can we define difficult-to-treat systemic sclerosis?
• Capi-score: a quantitative algorithm for identifying disease patterns in nailfold videocapillaroscopy
• Causes and predictors of death among Finnish patients with systemic sclerosis
• CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial
• Changes of cerebral structure and perfusion in subtypes of systemic sclerosis: a brain magnetic resonance imaging study
• Characterization of kidneys in patients with systemic sclerosis by multi-parametric magnetic resonance quantitative imaging
• Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients
• Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia
• Co-occurring livedoid vasculopathy and limited cutaneous systemic sclerosis associated gangrene successfully managed with alprostadil and aspirin
• Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression
• Contrasting effects of intracellular and extracellular human PCSK9 on inflammation, lipid alteration and cell death
• Contributions of Synthetic Chemicals to Autoimmune Disease Development and Occurrence
• Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis
• Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
• Development of a Musculoskeletal Ultrasound Protocol to Evaluate Hand Pain in Systemic Sclerosis Patients
• Developmental drugs for sarcoidosis
• Disrupting B and T cell Collaboration in Autoimmune Disease: T cell engagers versus CAR T cell therapy?
• Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
• Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial
• Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis
• Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog
• Evaluating the associations between dysautonomia, gastrointestinal transit, and clinical phenotype in patients with systemic sclerosis
• Examination of the shared genetic architecture between multiple sclerosis and systemic lupus erythematosus facilitates discovery of novel lupus risk loci
• Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines
• Gastric dysrhythmias in patients with early systemic sclerosis: a cross-sectional study
• Genetically Proxied Autoimmune Diseases and the Risk of Facial Aging
• Heart rate variability helps classify phenotype in systemic sclerosis
• HLA Association among Thai Patients with Diffuse and Limited Cutaneous Systemic Sclerosis
• Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation
• Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
• Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods study
• Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study
• Interstitial lung disease and myositis
• Investigation of dermal collagen nanostructures in Ehlers-Danlos Syndrome (EDS) patients
• Late-age onset systemic sclerosis-clinical and serological characteristics
• Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report
• Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome
• Lung ultrasound in the assessment of interstitial lung disease in patients with connective tissue disease: Performance in comparison with high-resolution computed tomography
• Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
• Mathematical modeling in autoimmune diseases: from theory to clinical application
• Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group
• Mesenchymal stem cells in autoimmune disease: A systematic review and meta-analysis of pre-clinical studies
• Mirtazapine Therapy for a Patient With Weight Loss and Gastroparesis Associated With Limited Systemic Sclerosis
• Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease
• Nodular/Keloidal Scleroderma with No Systemic Involvement-A Case Report and a Review of the Literature
• Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease
• Ocular Manifestation in Systemic Sclerosis-A Literature Review
• Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis
• Overlap Syndrome of Diffuse Systemic Sclerosis, Sjogren Syndrome, and ANCA-Associated Renal-Limited Vasculitis: Three Entities in One Patient - Case Report
• Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis
• Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis
• Polymyalgia Rheumatica During the Course of Limited Cutaneous Scleroderma: An Unusual and Challenging Coexistence
• Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases
• Predicting the Long-Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis
• Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis
• Pulmonary function in Thai patients with systemic sclerosis; a single center 6-year retrospective study
• Quality of sleep in individuals with systemic sclerosis and its correlation with functional disability and quality of life: a cross-sectional study
• Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosis
• Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study
• S2k guideline: Diagnosis and therapy of localized scleroderma
• Scleritis in Systemic Sclerosis Treated With Infliximab Biosimilar
• Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review
• Scleroderma: oral, maxillofacial and radiographic manifestations for dental practitioners
• Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis
• Shear wave elastography-derived scoring system: application in the detection, subdivision and evaluation of systemic sclerosis
• Skin Ultrasound Assessment of Patients with Systemic Scleroderma-An Observational Study
• Systemic diseases affecting the GI tract: A review of clinical and histopathologic manifestations
• Systemic Sclerosis in Males-Deciphering the Enigma of Erasmus Syndrome
• Systemic sclerosis sine scleroderma: a time of re-appraisal
• Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal
• Systemic sclerosis: one year in review 2024
• Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
• The effect of systemic sclerosis and its subtypes on ocular anterior and posterior segment parameters
• The gut microbiota-oligodendrocyte axis: A promising pathway for modulating oligodendrocyte homeostasis and demyelination-associated disorders
• The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases
• The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment
• The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review
• The Use of "Acellbia"-A Biosimilar of Rituximab in Systemic Sclerosis
• Topical Application of Nitrate Ameliorates Skin Fibrosis by Regulating ST2(+)CD4(+) T Cells in Systemic Sclerosis Mouse Model
• Topical sirolimus in dermatology: a systematic review
• Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry
• Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit
• Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts
• Use and perceptions of nutrition information resources in systemic sclerosis: a Scleroderma Patient-centred Intervention Network (SPIN) cohort study
• Using the Knowledge to Action framework to improve housing and support for people with Multiple Sclerosis
• Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update